Stocks · News reference
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Why Grindr generates $3M in revenue per employee, beating tech giants like Apple and Meta, and trailing only Nvidia in financial efficiency.
Retail investors talked up 5 hot stocks during week (Sept. 7 to Sept. 11) on X and Reddit's r/WallStreetBets: GME, AAPL, ADBE, ORCL, CASY.
Apple (AAPL) closed at $332.48, up 1.81% and outperforming the S&P 500's 0.86% gain. The stock has risen 6.98% over the past month. Analysts expect upcoming earnings of $1.98 per share (7.03% YoY growth) and revenue of $112.84 billion (10.12% YoY growth). However, Apple carries a premium valuation with a Forward P/E of 36.89 versus the industry average of 20, and a PEG ratio of 2.79 compared to the industry average of 1.7. The stock holds a Zacks Rank of #3 (Hold).
The article compares Amgen, an established pharmaceutical giant with $36.7B in revenue and a 2.60% dividend yield, against CRISPR Therapeutics, a gene-editing biotech pioneer with only $3.5M in revenue but groundbreaking CASGEVY therapy. While CRISPR offers high-growth potential, it remains unprofitable with significant losses. The author recommends Amgen for most investors seeking stability and predictable returns, though acknowledges CRISPR's improving commercial trajectory makes it a more compelling speculative opportunity than previously.
HSBC analyst Morten Herholdt downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and lowers the price target from $445 to $425.
Equities rebounded Friday as crude retreated from $100, though hot CPI pushed Fed hike odds to 90%. Dell jumped 11%on Oracle's capex plan.